Thanks to the Montreal Protocol, emissions of chlorofluorocarbons (CFCs) have dropped, resulting in early signs of recovery of the ozone layer. However, the battle is not yet won. Researchers report that nitrous oxide (N 2 O) -a gas that behaves similarly to CFCs in triggering global ozone destruction, but is not regulated by the protocol -is now the most significant ozone-depleter being emitted.
A. R. Ravishankara and his colleagues at the National Oceanic and Atmospheric Administration in Boulder, Colorado, calculated the 'ozone depletion potential' of N 2 O and used it to weight the current emissions level. They found that the 2008 weighted emissions level for N 2 O was around double that of the next most important ozone-depleting gas.
They also noted that nitrous oxide's globalwarming potential is second only to methane among non-carbon dioxide gases in terms of its contribution to warming.
STEM CELLS

Protein reprogramming
Cell Stem Cell 4, 381-384; 472-476 (2009) 387-389 (2009) Genome-wide association studies (GWAS) identify genomic regions associated with complex disease, but it can be difficult to pinpoint the exact gene or gene variant involved in the condition. Sergey Nejentsev at the University of Cambridge, UK, and his co-workers show how resequencing certain sections of the genome can bring researchers closer to an answer.
The group resequenced portions of 10 genes -which have been linked to diabetes or related syndromes -in 960 people, half of whom had type 1 diabetes. They then tested these genomic regions' association with diabetes in more than 30,000 people
Not from chimps
Science 326, 75-86 (2009) In October, after 17 years of investigation, researchers reported detailed descriptions of the oldest hominid skeleton yet found. The fairly complete 4.4-million-year-old female Ardipithecus ramidus fossil -known as Ardiwas discovered in Ethiopia.
Analysis of the remains by Tim White at the University of California, Berkeley, and a large team of collaborators revealed that humans did not evolve from ancient chimpanzees, as has long been believed. Humans instead evolved along a separate lineage from the last common ancestor shared by early hominids and extinct apes.
Like modern humans, Ardi could walk upright and didn't use her arms for walking, as chimps do. However, she retained a primitive big toe that could have been used in ape-like tree grasping.
Years of field work uncovered Ardi's skull, teeth, arms, hands, pelvis, legs and feet (composite photograph pictured). The paper is accompanied by 10 companion articles.
Medical School in Boston, Massachusetts, and their colleagues reprogrammed human fibroblasts. They used a human cell line to generate the proteins, fused with a cellpenetrating peptide.
These papers are just two from this year that improved methods of stem-cell reprogramming.
a visual task. The researchers simultaneously recorded local neuronal activity.
They showed that the initial part of the imaging signal is marked by changes in blood volume, not in blood oxygen levels. The authors concluded that blood volume is more tightly linked to neuronal activity and is thus a better measure to use in brain imaging. They say that boosting blood volume is the brain's way of 'anticipating' neuronal activity to meet the cells' impending need for more oxygen.
CLIMATE CHANGE
What's up with sea levels? Glob. Planet. Change 65, 83-88 (2009) Global warming causes sea levels to rise in two ways: by melting land ice and by thermally expanding ocean water. In the past, the two factors have proved difficult to accurately tease apart, but Anny Cazenave of the Laboratory for Studies in Space Geophysics and Oceanography (LEGOS) in Toulouse, France, and her colleagues succeeded in measuring the two processes separately. They used gravity data from the GRACE satellites and temperature records collected by the Argo network of buoys.
They calculate that the thermal expansion of sea water has slowed recently and contributed only 0.3 millimetres per year to sea-level rise between 2003 and 2008. Meanwhile, melting land ice caused ocean levels to increase by about 2 millimetres per year. The team also found that this gateway protein is present in the human choroid plexus and that a higher number of T cells from the spinal fluid of patients with multiple sclerosis express the CCR6 receptor.
CANCER DRUG DEVELOPMENT
Targeted tumour take-out N. Engl. J. Med. 361, 123-134 (2009) Tumour cells with a mutation that affects their ability to repair severed DNA can be killed with a drug that knocks out a second repair mechanism. That's the finding from a phase I clinical trial that enrolled patients with cancer-associated mutations in the BRCA DNA-repair genes.
Johann de Bono of the Institute of Cancer Research in Sutton, UK, and his co-workers gave patients olaparib, which inhibits an enzyme involved in a second DNA-repair pathway. Out of 19 patients with a BRCA mutation, 12 showed signs of tumour shrinkage or stabilization. (Pictured below: left, a computed tomography scan of the abdomen of one patient with ovarian cancer (circled); and right, showing complete tumour regression after four months of treatment.)
The study shows promise for using cancer molecular biology to devise personalized therapies that exploits a tumour's genetic or molecular defects.
BIOCHEMISTRY
Changing bases
Science 324, 930-935; 929-930 (2009) Modified versions of the four DNA basesadenine, thymine, cytosine and guaninecan serve special purposes. Parasitic protozoa called trypanosomes have a modified version of thymine called J that has not been documented in other organisms.
In a study published in May, Anjana Rao of Harvard Medical School in Boston and her colleagues searched for enzymes similar to those responsible for making base J that might generate a similar base in mammals. They found TET1, which converts a methylated cytosine to hydroxymethylcytosine. This altered version accounts for 4-6% of all cytosines in the DNA of mouse embryonic stem cells. The researchers think that this enzyme may regulate gene activity through this modification.
Meanwhile, independently, Skirmantas Kriaucionis and Nathaniel Heintz at the Rockefeller University in New York identified the modified base in the mouse brain.
MATERIALS CHEMISTRY
Marvellous metal-organics J. Am. Chem. Soc. 131, 2159 -2171 3625-3627 (2009) Metal-organic frameworks (MOFs) are porous materials with large surface areas that are made up of metals linked through organic groups. They are the focus of research for a range of applications, including hydrogen storage.
with and without the disease, and found four rare variants of the gene IFIH1 that seem to protect against diabetes. This gene is involved in the immune response to RNA viruses. The group concludes that resequencing can help to sort out causative from non-causative genes identified by GWAS.
Martin Schröder at the University of Nottingham, UK, and his colleagues investigated which parts of a series of copperbased MOFs (one of which is pictured, above) were responsible for increasing the hydrogentrapping ability of the materials. They showed that the shape of the linking groups and of the other chemical groups around the copper atoms were important. Bare copper sites held on to hydrogen the strongest. Pore size also affected how much hydrogen could be stored. One of the team's materials was able to store 7.78% by weight of hydrogen.
Another study from Anthony Cheetham at the University of Cambridge, UK, and his colleagues, showed that it is possible to make a multiferroic MOF -a material with more than one unique magnetic property. Multiferroic materials are hard to come by because they require the material to take on different molecular arrangements. But the team created a multiferroic MOF from manganese and organic groups, which might be used as magnetic-field sensors and in other devices.
